(Q46160839)

20 December 2017

title

Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes (English)

1 reference

20 December 2017

0 references

1 reference

10

Masaaki Inaba

1 reference

20 December 2017

author name string

Katsuhito Mori

1

1 reference

20 December 2017

Shuichi Jono

2

1 reference

20 December 2017

Masanori Emoto

3

1 reference

20 December 2017

Takahiko Kawagishi

4

1 reference

20 December 2017

Hideo Yasumoto

5

1 reference

20 December 2017

Toshiaki Konishi

6

1 reference

20 December 2017

Yutaka Furumitsu

7

1 reference

20 December 2017

Atsushi Shioi

8

1 reference

20 December 2017

Tetsuo Shoji

9

1 reference

20 December 2017

Yoshiki Nishizawa

11

1 reference

20 December 2017

publication date

14 January 2009

1 reference

20 December 2017

published in

Angiology

1 reference

20 December 2017

volume

61

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

86-91

1 reference

20 December 2017

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Statins: effective antiatherosclerotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Statins in the treatment of chronic heart failure: biological and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Dyslipidemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Effect of pravastatin on the development of diabetes and adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708330525

21 January 2018

Identifiers

DOI

10.1177/0003319708330525

1 reference

20 December 2017

1 reference

20 December 2017